Tonix Pharmaceuticals Holding Corp. SEC filings TNXP
Tonix Pharmaceuticals Holding Corp. has 1,000 filings in SEC EDGAR's recent list, going back to May 2, 2017. Its latest annual report, Form ARS, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jul 1, 2026 | — |
| 424B5 | Prospectus supplement | Dec 29, 2025 | — |
| 424B5 | Prospectus supplement | Nov 21, 2025 | — |
| S-3/A | Amendment to form s-3 | Sep 4, 2025 | — |
| S-3 | Shelf registration | Jun 12, 2025 | — |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| S-8 | Employee stock plan registration | May 30, 2025 | — |
| 424B5 | Prospectus supplement | Dec 20, 2024 | — |
| S-8 | Employee stock plan registration | Dec 6, 2024 | — |
| S-3 | Shelf registration | Sep 20, 2024 | — |
| 424B5 | Prospectus supplement | Aug 30, 2024 | — |
| 424B5 | Prospectus supplement | Jul 30, 2024 | — |
| 424B5 | Prospectus supplement | Jul 9, 2024 | — |
| 424B5 | Prospectus supplement | Jul 8, 2024 | — |
| 424B5 | Prospectus supplement | Jun 27, 2024 | — |
| 424B5 | Prospectus supplement | Jun 26, 2024 | — |
| 424B5 | Prospectus supplement | Jun 12, 2024 | — |
| 424B5 | Prospectus supplement | Jun 11, 2024 | — |
| 424B5 | Prospectus supplement | Mar 29, 2024 | — |
| 424B5 | Prospectus supplement | Dec 21, 2023 | — |
| 424B5 | Prospectus supplement | Dec 21, 2023 | — |
| 424B4 | Prospectus | Sep 29, 2023 | — |
| 424B5 | Prospectus supplement | Sep 28, 2023 | — |
| 424B5 | Prospectus supplement | Jul 28, 2023 | — |
| 424B5 | Prospectus supplement | Jul 27, 2023 | — |
| S-8 | Employee stock plan registration | Jun 16, 2023 | — |
| S-3 | Shelf registration | Aug 19, 2022 | — |
| 424B5 | Prospectus supplement | Aug 17, 2022 | — |
| 424B5 | Prospectus supplement | Aug 9, 2022 | — |
| S-8 | Employee stock plan registration | Jun 17, 2022 | — |
| 424B5 | Prospectus supplement | Dec 29, 2021 | — |
| 424B5 | Prospectus supplement | Dec 3, 2021 | — |
| S-8 | Employee stock plan registration | Jun 25, 2021 | — |
| 424B5 | Prospectus supplement | May 14, 2021 | — |
| S-3/A | Registration statement | Apr 23, 2021 | — |
| 424B5 | Prospectus supplement | Apr 19, 2021 | — |
| S-3 | Shelf registration | Apr 1, 2021 | — |
| 424B5 | Prospectus supplement | Feb 9, 2021 | — |
| 424B5 | Prospectus supplement | Jan 12, 2021 | — |
| S-3 | Shelf registration | Dec 18, 2020 | — |
| 424B5 | Prospectus supplement | Sep 4, 2020 | — |
| 424B5 | Prospectus supplement | Sep 4, 2020 | — |
| 424B5 | Prospectus supplement | Jul 14, 2020 | — |
| S-8 | Employee stock plan registration | Jun 12, 2020 | — |
| S-3 | Shelf registration | Apr 8, 2020 | — |
| 424B5 | Prospectus supplement | Feb 28, 2020 | — |
| 424B4 | Prospectus | Feb 11, 2020 | — |
| FWP | Free writing prospectus | Feb 6, 2020 | — |
| S-1/A | Amended registration statement | Feb 6, 2020 | — |
| FWP | Free writing prospectus | Feb 5, 2020 | — |
| FWP | Free writing prospectus | Jan 29, 2020 | — |
| S-1 | Registration statement | Jan 21, 2020 | — |
| 424B4 | Prospectus | Nov 18, 2019 | — |
| S-1/A | Amended registration statement | Nov 14, 2019 | — |
| S-1/A | Amended registration statement | Nov 14, 2019 | — |
| FWP | Free writing prospectus | Nov 8, 2019 | — |
| FWP | Free writing prospectus | Nov 1, 2019 | — |
| FWP | Free writing prospectus | Nov 1, 2019 | — |
| S-1 | Registration statement | Oct 18, 2019 | — |
| 424B3 | Prospectus | Sep 12, 2019 | — |
| S-1/A | Amended registration statement | Sep 6, 2019 | — |
| S-1 | Registration statement | Aug 23, 2019 | — |
| 424B4 | Prospectus | Jul 16, 2019 | — |
| S-1/A | Amended registration statement | Jul 15, 2019 | — |
| S-1/A | Amended registration statement | Jul 11, 2019 | — |
| FWP | Free writing prospectus | Jul 3, 2019 | — |
| S-1/A | Amended registration statement | Jul 1, 2019 | — |
| S-1 | Registration statement | Jun 19, 2019 | — |
| S-8 | Employee stock plan registration | Jun 14, 2019 | — |
| 424B4 | Prospectus | Dec 10, 2018 | — |
| S-1/A | Amended registration statement | Dec 6, 2018 | — |
| FWP | Free writing prospectus | Dec 3, 2018 | — |
| S-1/A | Amended registration statement | Dec 3, 2018 | — |
| S-1/A | Amended registration statement | Dec 3, 2018 | — |
| 424B3 | Prospectus | Nov 5, 2018 | — |
| S-1/A | Amended registration statement | Nov 2, 2018 | — |
| S-1 | Registration statement | Oct 24, 2018 | — |
| S-1 | Registration statement | Sep 7, 2018 | — |
| S-8 | Employee stock plan registration | Aug 10, 2018 | — |
| 424B3 | Prospectus | May 17, 2018 | — |
| S-3 | Shelf registration | May 1, 2018 | — |
| 424B3 | Prospectus | Oct 13, 2017 | — |
| S-1 | Registration statement | Sep 29, 2017 | — |
| S-3 | Shelf registration | Aug 11, 2017 | — |
| S-8 | Employee stock plan registration | Aug 11, 2017 | — |
| 424B5 | Prospectus supplement | Aug 1, 2017 | — |
Showing 87 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TNXP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Berkeley Heights, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1430306
- Former names
- TAMANDARE EXPLORATIONS INC. (until Oct 17, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.